BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38712529)

  • 1. ABCB1-mediated docetaxel resistance reversed by erastin in prostate cancer.
    Chen F; Wu S; Kuang N; Zeng Y; Li M; Xu C
    FEBS J; 2024 May; ():. PubMed ID: 38712529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer.
    Zhou HH; Chen X; Cai LY; Nan XW; Chen JH; Chen XX; Yang Y; Xing ZH; Wei MN; Li Y; Wang ST; Liu K; Shi Z; Yan XJ
    Front Oncol; 2019; 9():1398. PubMed ID: 31921655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer.
    Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.
    Li W; Zhai B; Zhi H; Li Y; Jia L; Ding C; Zhang B; You W
    Tumour Biol; 2014 Sep; 35(9):8883-91. PubMed ID: 24894670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer.
    Shan Y; Huang Y; Lee AM; Mentzer J; Ling A; Huang RS
    Front Oncol; 2021; 11():675215. PubMed ID: 34094978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
    Liu N; Lin X; Huang C
    Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer.
    Zhu Y; Liu C; Nadiminty N; Lou W; Tummala R; Evans CP; Gao AC
    Mol Cancer Ther; 2013 Sep; 12(9):1829-36. PubMed ID: 23861346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition.
    Qiu S; Deng L; Bao Y; Jin K; Tu X; Li J; Liao X; Liu Z; Yang L; Wei Q
    Anticancer Drugs; 2018 Oct; 29(9):871-879. PubMed ID: 29944470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer.
    Zhu Y; Liu C; Armstrong C; Lou W; Sandher A; Gao AC
    Clin Cancer Res; 2015 Sep; 21(18):4133-42. PubMed ID: 25995342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells.
    Li Y; Wang X; Chen YH; Tan QQ; Liu XB; Tan C
    Anticancer Drugs; 2024 Mar; 35(3):227-236. PubMed ID: 38085677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the
    Lombard AP; Lou W; Armstrong CM; D'Abronzo LS; Ning S; Evans CP; Gao AC
    Mol Cancer Ther; 2021 Oct; 20(10):2061-2070. PubMed ID: 34326198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer.
    Lombard AP; Liu C; Armstrong CM; Cucchiara V; Gu X; Lou W; Evans CP; Gao AC
    Mol Cancer Ther; 2017 Oct; 16(10):2257-2266. PubMed ID: 28698198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1.
    Seo HK; Lee SJ; Kwon WA; Jeong KC
    Prostate; 2020 May; 80(6):453-462. PubMed ID: 32134535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erastin induces apoptotic and ferroptotic cell death by inducing ROS accumulation by causing mitochondrial dysfunction in gastric cancer cell HGC‑27.
    Sun Y; Deng R; Zhang C
    Mol Med Rep; 2020 Oct; 22(4):2826-2832. PubMed ID: 32945484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels.
    Li M; Wang X; Lu S; He C; Wang C; Wang L; Wang X; Ge P; Song D
    Oncol Lett; 2020 Oct; 20(4):57. PubMed ID: 32793311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancer.
    Ku S; Lasorsa E; Adelaiye R; Ramakrishnan S; Ellis L; Pili R
    PLoS One; 2014; 9(7):e103680. PubMed ID: 25072314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.
    Mi YJ; Liang YJ; Huang HB; Zhao HY; Wu CP; Wang F; Tao LY; Zhang CZ; Dai CL; Tiwari AK; Ma XX; To KK; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2010 Oct; 70(20):7981-91. PubMed ID: 20876799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.